c.i. 42510 has been researched along with Lymphedema in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 9 (64.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooney, DS; Hassanein, AH; Sacks, JM | 1 |
Cakmakoglu, C; Djohan, R; Grobmyer, S; Schwarz, G; Shilad, S; Valente, S | 1 |
Annoscia, P; Elia, R; Giudice, G; Leuzzi, S; Maruccia, M; Nacchiero, E; Vestita, M | 1 |
Attalah, L; Ayestaray, B | 1 |
Adkins, L; Badgwell, B; Boneti, C; Klimberg, VS; Korourian, S; Ochoa, D | 1 |
Ansteth, M; Carl, A; Garreau, J; Glissmeyer, M; Johnson, N; Pasko, JL | 1 |
Hamdi, M; Seidenstuecker, K; Zeltzer, AA | 1 |
Lim, J; Lim, TC; Naidu, S; Ong, WC; Shim, TW; Yap, YL | 1 |
Eliška, O; Pavlista, D | 1 |
Andreoletti, JB; Ayestaray, B; Bekara, F | 1 |
Blanchard, DK; Donohue, JH; Grant, CS; Reynolds, C | 1 |
Clough, KB; Lecuru, F; Lesieur, B; Nos, C | 1 |
Engbaek, J; Freudendal-Pedersen, A; Krag, C; Larsen, VH; Partoft, S | 1 |
Bold, RJ; Fahy, BN; Schlieman, M | 1 |
1 review(s) available for c.i. 42510 and Lymphedema
Article | Year |
---|---|
Sentinel lymph node biopsy for breast cancer.
Topics: Aged; Axilla; Bibliometrics; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Coloring Agents; Contraindications; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Mastectomy; Middle Aged; Neoplasm Staging; Patient Care Team; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2001 |
13 other study(ies) available for c.i. 42510 and Lymphedema
Article | Year |
---|---|
Optimizing perioperative lymphatic-venous anastomosis localization using transcutaneous vein illumination, isosulfan blue, and indocyanine green lymphangiography.
Topics: Anastomosis, Surgical; Coloring Agents; Humans; Indocyanine Green; Lymphatic Vessels; Lymphedema; Lymphography; Rosaniline Dyes; Veins | 2017 |
Triple Mapping to Optimize Axillary Management in Breast Cancer Patients After Neoadjuvant Therapy.
Topics: Axilla; Biopsy; Breast Neoplasms; Coloring Agents; Female; Humans; Indocyanine Green; Lymph Nodes; Lymphatic Metastasis; Lymphedema; Neoadjuvant Therapy; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium | 2018 |
Lymphatic-venous anastomosis in a rat model: A novel exercise for microsurgical training.
Topics: Abdomen; Anastomosis, Surgical; Animals; Lymphatic Vessels; Lymphedema; Microsurgery; Models, Animal; Rats; Rosaniline Dyes; Veins | 2018 |
The value of Q-switched Nd:YAG laser after patent blue-enhanced lymphaticovenular anastomosis.
Topics: Anastomosis, Surgical; Coloring Agents; Female; Humans; Hyperpigmentation; Lasers, Solid-State; Low-Level Light Therapy; Lymphatic Vessels; Lymphedema; Middle Aged; Rosaniline Dyes; Veins | 2013 |
Axillary reverse mapping: five-year experience.
Topics: Axilla; Breast Neoplasms; Coloring Agents; Female; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Vessels; Lymphedema; Middle Aged; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2014 |
Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Incidence; Lymph Node Excision; Lymph Nodes; Lymphedema; Middle Aged; Retrospective Studies; Rosaniline Dyes; United States | 2015 |
Reply to "Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer".
Topics: Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphedema; Rosaniline Dyes | 2016 |
Patent blue dye in lymphaticovenular anastomosis.
Topics: Anastomosis, Surgical; Coloring Agents; Female; Humans; Lymphatic Metastasis; Lymphatic Vessels; Lymphedema; Mastectomy; Microsurgery; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2009 |
[Lymphatic mapping in axilla as possible prevention of lymphedema in breast cancer patients - first results of the anatomical study].
Topics: Aged; Arm; Axilla; Breast; Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Vessels; Lymphedema; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2012 |
Patent blue-enhanced lymphaticovenular anastomosis.
Topics: Aged; Anastomosis, Surgical; Chronic Disease; Cohort Studies; Female; Follow-Up Studies; Humans; Image Enhancement; Lymphatic Vessels; Lymphedema; Male; Microsurgery; Middle Aged; Retrospective Studies; Rosaniline Dyes; Treatment Outcome; Upper Extremity | 2013 |
Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Immunohistochemistry; Logistic Models; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Middle Aged; Morbidity; Neoplasm Recurrence, Local; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2003 |
Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
Topics: Adult; Aged; Aged, 80 and over; Arm; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Injections; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Middle Aged; Neoplasm Staging; Pilot Projects; Rosaniline Dyes | 2007 |
[False signs of hypoxemia when using the dye Patent Blue V].
Topics: Aged; Arm; False Positive Reactions; Female; Humans; Hypoxia; Lymphedema; Middle Aged; Oximetry; Postoperative Complications; Rosaniline Dyes | 1996 |